JP2002503687A5 - - Google Patents

Download PDF

Info

Publication number
JP2002503687A5
JP2002503687A5 JP2000532105A JP2000532105A JP2002503687A5 JP 2002503687 A5 JP2002503687 A5 JP 2002503687A5 JP 2000532105 A JP2000532105 A JP 2000532105A JP 2000532105 A JP2000532105 A JP 2000532105A JP 2002503687 A5 JP2002503687 A5 JP 2002503687A5
Authority
JP
Japan
Prior art keywords
active ingredient
inner ear
nucleic acid
acid molecule
ingredient according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000532105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002503687A (ja
Filing date
Publication date
Priority claimed from DE19807426A external-priority patent/DE19807426A1/de
Application filed filed Critical
Publication of JP2002503687A publication Critical patent/JP2002503687A/ja
Publication of JP2002503687A5 publication Critical patent/JP2002503687A5/ja
Pending legal-status Critical Current

Links

JP2000532105A 1998-02-23 1999-02-23 内耳の疾患又は機能障害の治療方法 Pending JP2002503687A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19807426A DE19807426A1 (de) 1998-02-23 1998-02-23 Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs
DE19807426.3 1998-02-23
PCT/EP1999/001153 WO1999042088A2 (de) 1998-02-23 1999-02-23 Verfahren zur behandlung von erkrankungen oder störungen des innenohrs

Publications (2)

Publication Number Publication Date
JP2002503687A JP2002503687A (ja) 2002-02-05
JP2002503687A5 true JP2002503687A5 (cg-RX-API-DMAC7.html) 2006-04-13

Family

ID=7858563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000532105A Pending JP2002503687A (ja) 1998-02-23 1999-02-23 内耳の疾患又は機能障害の治療方法

Country Status (11)

Country Link
US (1) US7087581B1 (cg-RX-API-DMAC7.html)
EP (1) EP1056467B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002503687A (cg-RX-API-DMAC7.html)
AT (1) ATE250936T1 (cg-RX-API-DMAC7.html)
AU (1) AU763868B2 (cg-RX-API-DMAC7.html)
CA (1) CA2320717C (cg-RX-API-DMAC7.html)
DE (2) DE19807426A1 (cg-RX-API-DMAC7.html)
DK (1) DK1056467T3 (cg-RX-API-DMAC7.html)
ES (1) ES2211055T3 (cg-RX-API-DMAC7.html)
PT (1) PT1056467E (cg-RX-API-DMAC7.html)
WO (1) WO1999042088A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2325198A1 (en) 1999-06-01 2011-05-25 Baylor College Of Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence
DE10027777A1 (de) * 2000-06-07 2001-12-13 Otogene Ag Transfektionsverfahren
EP1307542A2 (en) * 2000-07-11 2003-05-07 Sound Pharmaceuticals Incorporated Stimulation of cellular regeneration and differentiation in the inner ear
AU2003268741B2 (en) 2002-10-02 2009-06-11 Anges Mg, Inc. Drug for auditory dysfunction
DE60323876D1 (de) * 2002-12-17 2008-11-13 Centre Nat Rech Scient Verwendung von purinderivaten zur induktion der differenzierung überzähliger haarzellen und deiter-zellen im entwickelnden corti-organ zur behandlung von taubheit
US8431692B2 (en) * 2008-06-06 2013-04-30 Quark Pharmaceuticals, Inc. Compositions and methods for treatment of ear disorders
DE102010007281A1 (de) 2010-02-08 2011-08-11 EMC microcollections GmbH, 72070 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
RU2480195C1 (ru) * 2011-11-02 2013-04-27 Федеральное государственное учреждение "Российский научный центр восстановительной медицины и курортологии Федерального агентства по здравоохранению и социальному развитию РФ" (ФГУ "РНЦВМиК Росздрава РФ") Способ лечения заболеваний внутреннего уха
EP2802657B1 (en) 2012-01-12 2018-05-02 Quark Pharmaceuticals, Inc. Combination therapy for treating hearing and balance disorders
US20150079110A1 (en) * 2012-03-05 2015-03-19 Wake Forest University Health Sciences Regeneration of inner ear cells
TWI710635B (zh) 2014-10-09 2020-11-21 美商珍維克公司 編碼人類無調同源物-1(hath1)之腺病毒載體

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528388A1 (de) 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
AU727037B2 (en) 1995-11-13 2000-11-30 Cenes Pharmaceuticals, Inc. Methods of treating disorders of non-visual sensory epithelia
US5962224A (en) * 1995-12-19 1999-10-05 Dana-Farber Cancer Institute Isolated DNA encoding p62 polypeptides and uses therefor
WO1998000014A1 (en) * 1996-06-28 1998-01-08 The Regents Of The University Of California Transformation and genetherapy of cells of the inner ear
WO1998013048A1 (en) 1996-09-27 1998-04-02 Trustees Of The University Of Pennsylvania Novel methods for inducing proliferation in auditory receptor epithelium
US6043221A (en) * 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product

Similar Documents

Publication Publication Date Title
WO2002004623A3 (en) ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE
EP1327449A4 (en) MEDICINE FOR THE TREATMENT OF ISCHEMIC ILLNESSES
WO2001098290A3 (en) Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
RU2001126526A (ru) Лекарственное средство, предназначенное для лечения диабета
EE200200211A (et) Bitsüklilised aminohapped kui farmatseutilised toimeained
WO1994006449A3 (en) Morphogen-induced liver regeneration
JP2004527551A5 (cg-RX-API-DMAC7.html)
AU2023401A (en) A rapid acting freeze dired oral pharmaceutical composition for treating migraine
JP2002528412A5 (cg-RX-API-DMAC7.html)
WO2003015779A3 (de) Matrixkontrolliertes transdermales therapeutisches system zur anwendung von pramipexol und ropinirol
WO2005014572A8 (en) Pyrimidylpyrrole derivatives active as kinase inhibitors
AU2002341366A1 (en) Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucuous membranes
JP2004537500A5 (cg-RX-API-DMAC7.html)
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
WO2004034962A3 (en) Selective cytokine inhibitory drugs for treating myelodysplastic syndrome
WO2001034641A8 (en) Antimicrobial activity of the first cationic cluster of human lactoferrin
CA2348882A1 (en) Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
JP2002530353A5 (cg-RX-API-DMAC7.html)
RU2002130719A (ru) Композиция, обладающая активирующей активностью
EP1090635A3 (en) Use of ferulic acid for treating hypertension
AU5158000A (en) Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
JP2002503687A (ja) 内耳の疾患又は機能障害の治療方法
SE9900177D0 (sv) Vårtmedel
WO2001080891A8 (en) Remedies for interstitial pneumonia, method of constructing animal model of this disease and screening method with the use of the same
CA2429793A1 (en) Interferon therapeutic effect enhancer